Lamivudine
NDC 65862-026, Lamivudine, tablet, film coated, from Aurobindo Pharma Limited.
- Product NDC
- 65862-026
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077464
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65862-026 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LAMIVUDINE300 mg/1
Pharmacologic classes
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65862-026-10 | 65862002610 | 3 BLISTER PACK in 1 CARTON (65862-026-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK |
| 65862-026-30 | 65862002630 | 30 TABLET, FILM COATED in 1 BOTTLE (65862-026-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a8a492ab-396a-4b7c-99b3-bcb6d3386f71
Use it
Look up 65862-026 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65862-026 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65862-026. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.